CIPROFLOXACIN TEVA 250 MG
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
CIPROFLOXACIN AS HYDROCHLORIDE
Available from:
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
ATC code:
S03AA07
Pharmaceutical form:
TABLETS
Composition:
CIPROFLOXACIN AS HYDROCHLORIDE 250 MG
Administration route:
PER OS
Prescription type:
Required
Manufactured by:
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
Therapeutic group:
CIPROFLOXACIN
Therapeutic area:
CIPROFLOXACIN
Therapeutic indications:
Broad spectrum antibiotic for infections caused by ciprofloxacin sensitive pathogens: invasive infections of the external ear. Treatment of acute pulmonary exacerbation of cystic fibrosis associated with P. aeruginosa infections in pediatric patients aged 5-17 years.
Authorization date:
2012-03-31
